Welcome to our dedicated page for CASCADIA MINERALS news (Ticker: CAMNF), a resource for investors and traders seeking the latest updates and insights on CASCADIA MINERALS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CASCADIA MINERALS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CASCADIA MINERALS's position in the market.
Michael Gentile has filed an early warning report announcing the acquisition of 260,500 common shares of Cascadia Minerals (CAMNF). Prior to this acquisition, Gentile owned 3,160,000 common shares and 2,324,300 warrants, representing about 6.01% of the company's shares on an undiluted basis and 9.99% on a partially diluted basis. After the acquisition, Gentile now owns 3,420,500 common shares and 2,324,300 warrants, increasing his stake to approximately 6.51% undiluted and 10.47% partially diluted. The shares were acquired for investment purposes, with Gentile maintaining a long-term view of the investment.
FAQ
What is the current stock price of CASCADIA MINERALS (CAMNF)?
What is the market cap of CASCADIA MINERALS (CAMNF)?
